Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells
Published inCancer research, vol. 63, no. 2, p. 534-540
Publication date2003
Abstract
Keywords
- Antibodies, Monoclonal/ pharmacology
- Antigens, CD20/ metabolism
- Antigens, CD55/metabolism
- Antineoplastic Agents/ pharmacology
- Cyclodextrins/chemistry
- Glucosides/chemistry
- Humans
- Lymphoma, B-Cell/drug therapy/ metabolism
- Membrane Lipids/metabolism
- Membrane Microdomains/drug effects/ metabolism
- Membrane Proteins/metabolism
- Phospholipase D/metabolism
- Phosphoproteins/metabolism
- Type C Phospholipases/metabolism
- beta-Cyclodextrins
- src-Family Kinases/metabolism
Affiliation entities Not a UNIGE publication
Citation (ISO format)
SEMAC, Isabelle et al. Anti-CD20 therapeutic antibody rituximab modifies the functional organization of rafts/microdomains of B lymphoma cells. In: Cancer research, 2003, vol. 63, n° 2, p. 534–540.
Main files (1)
Article
Identifiers
- PID : unige:11579
- PMID : 12543813
Additional URL for this publicationhttp://cancerres.aacrjournals.org/content/63/2/534.full.pdf
Journal ISSN0008-5472